Demand for CBD products in the U.S. continues to soar. But the best way to ACCESS that demand today is via hemp oil products.
Legalization advocates have long argued that marijuana represents a potentially effective treatment option for chronic pain and could serve as an alternative to opioid-based painkillers—and according to a new scientific meta-analysis, they may be onto something.
In a "bad" year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That's not bad.
InMed Pharmaceuticals has isolated the rare cannabinoid, cannabinol, in two cannabinoid-based drugs currently in clinical trials.
The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?
As Canadian cannabis retailers gather momentum, Choom Holdings provides investors with a very attractive value proposition.
Tetra Bio-Pharma takes another step forward in bringing a botanical cannabinoid drug to market for pain relief.
Fire & Flower Holdings is Canada's new retailing leader in stores as it reports opening its 46th cannabis store.
As the U.S. Cannabis Revolution unfolds, over 90% of Americans now want cannabis legalized (at least) for medical purposes. Attention Congress.
The new cannabis store licensing system has commenced in Ontario. Total retail cannabis stores could multiply by nearly a factor of 10 in 2020.